GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Selling and Marketing Expense

Cytogen (XKRX:217330) Selling and Marketing Expense : ₩1,708 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cytogen Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Cytogen's Selling and Marketing Expense for the three months ended in Mar. 2024 was ₩530 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,708 Mil.

Cytogen Selling and Marketing Expense Historical Data

The historical data trend for Cytogen's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Selling and Marketing Expense Chart

Cytogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 402.04 533.22 837.62 1,463.97 1,612.91

Cytogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 435.67 400.17 229.35 547.72 530.35

Cytogen Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,708 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytogen Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Cytogen's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytogen (XKRX:217330) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:084650 XKRX:384470 XKRX:950130 XKRX:180400 XKRX:038290 XKRX:376930 XKRX:051980 XKRX:153710 XKRX:950200 XKRX:363250 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854
Website
http://www.cytogenlab.com
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines